Renal Insufficiency in Non-Diabetic Subjects: Relationship of MTHFR C677t Gene Polymorphism and Left Ventricular Hypertrophy

REFERENCES

• Fung MM, Salem RM, Lipkowitz MS, Methylenetetrahydrofolate reductase (MTHFR) polymorphism A1298C (Glu429Ala) predicts decline in renal function over time in the African-American Study of Kidney Disease and Hypertension (AASK) Trial and Veterans Affairs Hypertension Cohort (VAHC). Nephrol Dial Transplant. 2012;27:197–205.
   PubMed Web of Science ®Google Scholar
• Morita H, Taguchi J, Kurihara H, A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis. 1997;128:107–112.
   PubMed Web of Science ®Google Scholar
• Minamino T, Ohno M, Yamaoki K, Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation. 1997;95:2032–2036.
   PubMed Web of Science ®Google Scholar
• van Bockxmeer FM, Mamotte CD, Vasikaran SD, Taylor RR. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation. 1997;95:21–23.
   PubMed Web of Science ®Google Scholar
• Deloughery TG, Evans A, Sadeghi A, Common mutation in methylenetetrahydrofolate reductase. Correlation with homocysteine metabolism and late-onset vascular disease. Circulation. 1996;94:3074–3078.
   PubMed Web of Science ®Google Scholar
• Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation. 1993;88(4 Pt 1):1463–1469.
   PubMed Web of Science ®Google Scholar
• Gülec S, Aras O, Akar E, Tutar E, Methylene-tetrahydro-folate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol. 2001;24:281–284.
   PubMed Web of Science ®Google Scholar
• Brattström L, Zhang Y, Hurtig M, A common methylenetetrahydrofolate reductase gene mutation and longevity. Atherosclerosis. 1998;141:315–319.
   PubMed Web of Science ®Google Scholar
• Agodi A, Barchitta M, Cipresso R, Distribution of p53, GST, and MTHFR polymorphisms and risk of cervical intraepithelial lesions in Sicily. Int J Gynecol Cancer. 2010;20:141–146.
   PubMed Web of Science ®Google Scholar
• Chen J, Giovannucci E, Kelsey K, A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 1996;56:4862–4864.
   PubMed Web of Science ®Google Scholar
• Martínez ME, Thompson P, Jacobs ET, Dietary factors and biomarkers involved in the methylenetetrahydrofolate reductase genotype-colorectal adenoma pathway. Gastroenterology. 2006;131:1706–1716.
   PubMed Web of Science ®Google Scholar
• Lee JE, Wei EK, Fuchs CS, Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control. 2012;23:537–545.
   PubMed Web of Science ®Google Scholar
• Rea IM, McMaster D, Woodside JV, Community-living nonagenarians in Northern Ireland have lower plasma homocysteine but similar methylenetetrahydrofolate reductase thermolabile genotype prevalence compared to 70-89-year-old subjects. Atherosclerosis. 2000;149:207–214.
   PubMed Web of Science ®Google Scholar
• Ravera M, Viazzi F, Berruti V, 5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. Am J Hypertens. 2001;14(4 Pt 1):371–376.
   PubMed Web of Science ®Google Scholar
• Dedoussis GV, Panagiotakos DB, Pitsavos C, ATTICA Study Group. An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease. Int J Cardiol. 2005;100:409–414.
   PubMed Web of Science ®Google Scholar
• Trovato GM, Pirri C, Martines GF, Trovato F, Catalano D. Coffee, nutritional status, and renal artery resistive index. Ren Fail. 2010;32:1137–1147.
   PubMed Web of Science ®Google Scholar
• Greaves K, Chen R, Ge L, Mild to moderate renal impairment is associated with increased left ventricular mass. Int J Cardiol. 2008;124:384–386.
   PubMed Web of Science ®Google Scholar
• Hsieh MC, Su HM, Wang SY, Significant correlation between left ventricular systolic and diastolic dysfunction and decreased glomerular filtration rate. Ren Fail. 2011;33:977–982.
   PubMed Web of Science ®Google Scholar
• Rodrigues SL, Angelo LC, Pereira AC, Krieger JE, Mill JG. Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals. Int J Cardiol. 2009;135:323–330.
   PubMed Web of Science ®Google Scholar
• Lai CL, Chien KL, Hsu HC, Su TC, Chen MF, Lee YT. Left ventricular mass and risk of cardiovascular events and all-cause death among ethnic Chinese – the Chin-Shan Community Cardiovascular Cohort study. Int J Cardiol. 2011;149:347–352.
   PubMed Web of Science ®Google Scholar
• Rivera Otero JM, Taléns-Visconti R, Salvador A, Grupo de Disfunción VI, Comunidad Valenciana. Ventricular hypertrophy increases NT-proBNP in subjects with and without hypertension. Int J Cardiol. 2004;96:265–271.
   PubMed Web of Science ®Google Scholar
• de Ruijter W, Westendorp RG, Assendelft WJ, Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009;338:a3083–a3090.
   PubMed Web of Science ®Google Scholar
• Wald DS, Law M, Morris JK. The dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screening. Eur J Cardiovasc Prev Rehabil. 2004;11:250–253.
   PubMedGoogle Scholar
• Brattström L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr. 2000;72:315–323.
   PubMed Web of Science ®Google Scholar
• Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324–332.
   PubMed Web of Science ®Google Scholar
• Kopple JD. The phenomenon of altered risk factor patterns or reverse epidemiology in persons with advanced chronic kidney failure. Am J Clin Nutr. 2005;81:1257–1266.
   PubMed Web of Science ®Google Scholar
• Dedoussis GV, Panagiotakos DB, Chrysohoou C, Effect of interaction between adherence to a Mediterranean Diet and the methylenetetrahydrofolate reductase 677C–>T mutation on homocysteine concentrations in healthy adults: the ATTICA Study. Am J Clin Nutr. 2004;80:849–854.
   PubMed Web of Science ®Google Scholar
• Doehner W, Clark A, Anker SD. The obesity paradox: weighing the benefit. Eur Heart J. 2010;31:146–148.
   PubMed Web of Science ®Google Scholar
• Tublin ME, Bude RO, Platt JF. Review. The resistive index in renal Doppler sonography: where do we stand? AJR Am J Roentgenol. 2003;180:885–892.
   PubMed Web of Science ®Google Scholar
• Heine GH, Reichart B, Ulrich C, Köhler H, Girndt M. Do ultrasound renal resistance indices reflect systemic rather than renal vascular damage in chronic kidney disease? Nephrol Dial Transplant. 2007;22:163–170.
   PubMed Web of Science ®Google Scholar
• Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003;24:2054–2060.
   PubMed Web of Science ®Google Scholar
• Anderson JL, Vanwoerkom RC, Horne BD, . Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J. 2011;162:331–339.
   PubMed Web of Science ®Google Scholar
• Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Catalano D. Renal resistive index and parathyroid hormone relationship with renal function in nondiabetic patients. Endocr Res. 2012;37:47–58.
   PubMed Web of Science ®Google Scholar
• Bell DS. Insulin resistance. An often unrecognized problem accompanying chronic medical disorders. Postgrad Med. 1993;93(99-103):106–107.
   Google Scholar
• Pitsavos C, Panagiotakos DB, Chrysohoou C, Stefanadis C. Epidemiology of cardiovascular risk factors in Greece: aims, design and baseline characteristics of the ATTICA study. BMC Publ Health. 2003;3:32–40.
   PubMed Web of Science ®Google Scholar
• Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A. Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int. 2008;28:1280–1287.
   PubMed Web of Science ®Google Scholar
• Dai J, Jones DP, Goldberg J, Association between adherence to the Mediterranean Diet and oxidative stress. Am J Clin Nutr. 2008;88:1364–1370.
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Kouris-Blazos A, Wahlqvist ML, Diet and overall survival in elderly people. BMJ. 1995;31:1457–1460.
   Google Scholar
• Trichopoulou A, Vasilopoulou E. Mediterranean Diet and longevity. Br J Nutr. 2000;84(Suppl 2):S205–S209.
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean Diet and survival in a Greek population. N Engl J Med. 2003;348:2599–2608.
   PubMed Web of Science ®Google Scholar
• Bravata DM, Smith-Spangler C, Sundaram V, Using pedometers to increase physical activity and improve health: a systematic review. J Am Med Assoc. 2007;298:2296–2304.
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl 3):S1–S201.
   Web of Science ®Google Scholar
• La’ulu SL, Rawlins ML, Pfeiffer CM, Zhang M, Roberts WL. Performance characteristics of six homocysteine assays. Am J Clin Pathol. 2008;130:969–975.
   PubMed Web of Science ®Google Scholar
• Rutter MK, Wilson PW, Sullivan LM, Fox CS, D’Agostino RBSr, Meigs JB. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation. 2008;117:1003–1009.
   PubMed Web of Science ®Google Scholar
• Trovato GM, Catalano D, Sciacchitano G, Zuccalà G, Iannetti E. Resistive index of renal artery and blood pressure in postmenopausal women. Maturitas. 2002;41:223–230.
   PubMed Web of Science ®Google Scholar
• Trovato GM, Pirri C, Martines GF, Tonzuso A, Trovato F, Catalano D. Lifestyle interventions, insulin resistance, and renal artery stiffness in essential hypertension. Clin Exp Hypertens. 2010;32:262–269.
   PubMed Web of Science ®Google Scholar
• Gardin JM, Adams DB, Douglas PS, American Society of Echocardiography. Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of chocardiography’s Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr. 2002;15:275–290.
   PubMed Web of Science ®Google Scholar
• Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–1083.
   PubMed Web of Science ®Google Scholar
• Woythaler JN, Singer SL, Kwan OL, Accuracy of echocardiography versus electrocardiography in detecting left ventricular hypertrophy: comparison with postmortem mass measurements. J Am Coll Cardiol. 1983;2:305–311.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450–458.
   PubMed Web of Science ®Google Scholar
• Guéant-Rodriguez RM, Guéant JL, Debard R, Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr. 2006;83:701–707.
   PubMed Web of Science ®Google Scholar
• Foppa M, Duncan BB, Rohde LE. Echocardiography-based left ventricular mass estimation. How should we define hypertrophy? Cardiovasc Ultrasound. 2005;3:17–30.
   PubMedGoogle Scholar
• Smith GL, Lichtman JH, Bracken MB, Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol. 2006;47:1987–1996.
   PubMed Web of Science ®Google Scholar
• Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertens Res. 2007;30:1177–1185.
   PubMed Web of Science ®Google Scholar
• Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease; a review. Eur Heart J. 2004;25:1776–1787.
   PubMed Web of Science ®Google Scholar
• Fox ER, Benjamin EJ, Sarpong DF, The relation of C–reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study. BMC Nephrol. 2010;11:1–7.
   PubMed Web of Science ®Google Scholar
• Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011;80:806–821.
   PubMed Web of Science ®Google Scholar
• Petersen LJ, Petersen JR, Talleruphuus U, Ladefoged SD, Mehlsen J, Jensen HA. The pulsatility index and the resistive index in renal arteries. Associations with long-term progression in chronic renal failure. Nephrol Dial Transplant. 1997;12: 1376–1380.
   PubMed Web of Science ®Google Scholar
• Catalano D, Trovato GM, Martines GF, Pirri C, Trovato FM. Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate. Hepatol Int. 2011;5:822–829.
   PubMed Web of Science ®Google Scholar
• Maurer M, Burri S, de Marchi S, Plasma homocysteine and cardiovascular risk in heart failure with and without cardiorenal syndrome. Int J Cardiol. 2010;141:32–38.
   PubMed Web of Science ®Google Scholar
• Yi F, Li PL. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol. 2008;28:254–264.
   PubMed Web of Science ®Google Scholar
• Rutter MK, Parise H, Benjamin EJ, Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448–454.
   PubMed Web of Science ®Google Scholar
• Velagaleti RS, Gona P, Chuang ML, Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010;3:257–263.
   PubMed Web of Science ®Google Scholar
• Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab. 2012;97:1268–1276.
   PubMed Web of Science ®Google Scholar
• Zoungas S, McGrath BP, Branley P, Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol. 2006;47:1108–1116.
   PubMed Web of Science ®Google Scholar
• Boner G. Renal involvement and left ventricular hypertrophy are novel risk factors for morbidity and mortality in diabetes mellitus. Diabetes Metab Res Rev. 2011;27:425–429.
   PubMed Web of Science ®Google Scholar
• Florea VG, Mareyev VY, Samko AN, Orlova IA, Coats AJ, Belenkov YN. Left ventricular remodelling: common process in patients with different primary myocardial disorders. Int J Cardiol. 1999;68:281–287.
   PubMed Web of Science ®Google Scholar
• Thomas MD, Fox KF, Coats AJ. Redefining heart failure. Int J Cardiol. 2006;112:139–141.
   PubMed Web of Science ®Google Scholar
• de Lorgeril M, Salen P. Mediterranean Diet in secondary prevention of CHD. Public Health Nutr. 2011;14:2333–2337.
   PubMed Web of Science ®Google Scholar
• Coats AJ. Advances in the non-drug, non-surgical, non-device management of chronic heart failure. Int J Cardiol. 2005;100:1–4.
   PubMed Web of Science ®Google Scholar
• Chrysohoou C, Panagiotakos DB, Pitsavos C, Adherence to the Mediterranean Diet is associated with renal function among healthy adults: the ATTICA study. J Ren Nutr. 2010;20:176–184.
   PubMed Web of Science ®Google Scholar
• Pereira AC, Miyakawa AA, Lopes NH, Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization. Thromb Res. 2007;121:25–32.
   PubMed Web of Science ®Google Scholar
• Kalina A, Czeizel AE. The methylenetetrahydrofolate reductase gene polymorphism (C677T) is associated with increased cardiovascular mortality in Hungary. Int J Cardiol. 2004;97:333–334.
   PubMed Web of Science ®Google Scholar
• Collings A, Raitakari OT, Juonala M, Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the cardiovascular risk in Young Finns Study. Scand J Clin Lab Invest. 2008;68:22–30.
   PubMed Web of Science ®Google Scholar
• Schmitz C, Lindpaintner K, Verhoef P, Gaziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction: a case-control study. Circulation. 1996;94:1812–1814.
   PubMedGoogle Scholar
• Yang Q, Bailey L, Clarke R, Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults. Am J Clin Nutr. 2012;95:1245–1253.
   PubMed Web of Science ®Google Scholar
• Schofield RS, Wessel TR, Walker TC, Cleeton TS, Hill JA, Aranda JM Jr. Hyper-homocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations. Clin Cardiol. 2003;26:407–410.
   PubMed Web of Science ®Google Scholar
• Bowden RG, Wyatt FB, Wilson R, Wilborn C, Gentile M. Homocysteine and vascular access thrombosis in a cohort of end-stage renal disease patients. Ren Fail. 2004;26:709–714.
   PubMed Web of Science ®Google Scholar